gdc
CholangiocarcinomaSlideshows

February Is Gallbladder and Bile Duct Cancer Awareness Month

View this slideshow to learn important facts about Gallbladder and bile duct cancer, including statistics, causes and symptoms.
Web Exclusives – February 1, 2019
  • FebSlideshow01
  • FebSlideshow02
  • FebSlideshow03
  • FebSlideshow04
  • FebSlideshow05
  • CQ Generic SlideshowEnder 800
Recommended For You
Skin CancerSlideshows
July is UVC Safety Awareness Month
View this slideshow to learn how to protect yourself from harmful ultraviolet radiation.
BiomarkersCholangiocarcinomaGenetics & Cancer
Biomarker Testing Crucial for Patients with Cholangiocarcinoma
By Wayne Kuznar
New treatments are becoming available for patients with cholangiocarcinoma (bile duct cancer). Testing for specific biomarkers is crucial to ensure each patient receives the best available treatment for any associated biomarker.
CholangiocarcinomaFDA Approvals, News & Updates
Pemazyre First Therapy Approved for Cholangiocarcinoma with FGFR2 Biomarker
In April, the FDA approved Pemazyre, the first targeted drug for patients with advanced cholangiocarcinoma and a biomarker called FGFR2 gene fusion.
Appendix CancerSlideshows
Quick Facts on Appendix Cancer
Appendix cancer or appendiceal cancer is rare, occurring in about 1,000 people in the United States each year. View this slideshow to learn important facts about appendix cancer, including statistics, causes and symptoms.
Last modified: February 12, 2020

Subscribe to CONQUER: the patient voice magazine

Receive timely cancer news & updates, patient stories, and more.

Country